Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)
China flag China · Delayed Price · Currency is CNY
24.70
+0.05 (0.20%)
Feb 13, 2026, 3:00 PM CST

SHA:605016 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,3791,107854.14696.18638.52
Other Revenue
-4514.1225.7114.83
1,3791,152868.26721.89653.36
Revenue Growth (YoY)
19.75%32.64%20.28%10.49%30.77%
Cost of Revenue
946.84764.89584.2493.41471.72
Gross Profit
432.22386.76284.06228.49181.64
Selling, General & Admin
-67.5447.7745.0540.35
Research & Development
-44.4632.5627.0323.26
Other Operating Expenses
-9.687.615.995.67
Operating Expenses
-127.9290.6182.8171.65
Operating Income
432.22258.84193.45145.68109.98
Interest Expense
--2.66-2.25-0.07-1.04
Interest & Investment Income
-9.6112.1412.765.04
Currency Exchange Gain (Loss)
-8.174.1310.28-2.76
Other Non Operating Income (Expenses)
-0.58-0.43-0.21-0.13-0.14
EBT Excluding Unusual Items
431.63273.53207.27168.52111.09
Gain (Loss) on Sale of Investments
-1.272.703.35
Gain (Loss) on Sale of Assets
--0.39-2.13-3.15-1.26
Asset Writedown
-----1.73
Other Unusual Items
-10.8913.687.717.32
Pretax Income
431.63285.31221.52173.09118.77
Income Tax Expense
65.8539.7128.5222.3414.29
Net Income
365.78245.6193150.75104.48
Net Income to Common
365.78245.6193150.75104.48
Net Income Growth
48.94%27.26%28.02%44.29%9.34%
Shares Outstanding (Basic)
420420418418385
Shares Outstanding (Diluted)
420420418418385
Shares Change (YoY)
0.08%0.46%0.12%8.63%22.70%
EPS (Basic)
0.870.580.460.360.27
EPS (Diluted)
0.870.580.460.360.27
EPS Growth
48.82%26.67%27.88%32.83%-10.89%
Free Cash Flow
-19.09-117.34-25.7840.38
Free Cash Flow Per Share
-0.04-0.28-0.060.10
Dividend Per Share
-0.1460.1420.0720.026
Dividend Growth
-2.96%97.50%180.86%-
Gross Margin
31.34%33.58%32.72%31.65%27.80%
Operating Margin
31.34%22.48%22.28%20.18%16.83%
Profit Margin
26.52%21.33%22.23%20.88%15.99%
Free Cash Flow Margin
-1.66%-13.51%-3.57%6.18%
EBITDA
507.6334.22238.38192.42156.51
EBITDA Margin
36.81%29.02%27.46%26.66%23.96%
D&A For EBITDA
75.3875.3844.9346.7546.53
EBIT
432.22258.84193.45145.68109.98
EBIT Margin
31.34%22.48%22.28%20.18%16.83%
Effective Tax Rate
15.26%13.92%12.88%12.91%12.04%
Revenue as Reported
-1,152868.26721.89653.36
Advertising Expenses
-3.482.91.131.25
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.